1 Character

This product is white film-coated tablets, and will show yellow double-layer tablet after removing the coating.

2 Drug Description

RoToFie (Glipizide Extended Release Tablets), the first Generic Drug Consistency Evaluation of Glipizide Extended Released Tablets certified in China, is the new generation hypoglycemic drug self-developed by Beijing Honglin Pharmaceutical, the patent will not expire before 2029.

RoToFier is an osmotic pump controlled-release preparation and the latest developed preparation of the third generation. Oral Hypoglycemic Medication is the effective therapy for type II diabetes, among them, insulin secretagogues is constantly the one of the referred medication from domestic and international authorities, among which Glipizide Extended-Release Tablets is one of the classics.

3 Usage and Dosage

Medication should be taken together with breakfast or the 1st meal of the day, recommended initial dosage is 5mg per dose and 1 dose a day. (Please follow the  Users manuals)

4 Technology 

Utilizes a bi-layer osmotic pump delievery system.

5 Friendly Reminders

Tablets should be swallowed, can't be chewed, divided and smashed. Tablet like object could be visualized in the feaces, API is contained in an anti-dissolvable crust on the purpose of making the ingredients being stably and slowly released and being absorbed by the body of patients.

6 Package 

5mg X 14/21/28 tablets

7 Status 

Prescription (Rx) drug.

"Please take the drugs following the user manuals or under doctors' prescription."

RoToFier (Glipizide Extened Release tablets).pdf